Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
Autoimmune Disorder Multiple Sclerosis (MS)
Study results
LPS_MA30005_CASTING_final results_Octobre2020_Czech
(PDF, 0.6 MB)
LPS_MA30005_CASTING_final results_Octobre2020_Danish
(PDF, 0.2 MB)
LPS_MA30005_CASTING_final results_Octobre2020_Dutch_Belgium
(PDF, 0.5 MB)
LPS_MA30005_CASTING_final results_Octobre2020_French_Belgium
(PDF, 0.5 MB)
LPS_MA30005_CASTING_final results_Octobre2020_Italian
(PDF, 0.7 MB)
LPS_MA30005_CASTING_final results_Octobre2020_Norwegian
(PDF, 0.7 MB)
LPS_MA30005_CASTING_final results_Octobre2020_Spanish_Spain
(PDF, 0.7 MB)
LPS_MA30005_CASTING_final results_Sept2021_English
(PDF, 2.1 MB)
LPS_MA30005_CASTING_final results_December2021_Switzerland_French
(PDF, 0.6 MB)
LPS_MA30005_CASTING_final results_December2021_Switzerland_German
(PDF, 0.4 MB)
LPS_MA30005_CASTING_final results_September2021_German
(PDF, 0.8 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com